Disclaimer: This is not financial or investment advice. You are responsible for any capital-related decisions you make, and only you are accountable for the results.
Daily timeframe analysis
Injective ($INJ) is currently trading at $20.2 and struggling to break above the 200 EMA on the daily timeframe, which is sitting around $22.45. This EMA has acted as a strong resistance level, causing the price to squeeze into a tight range.Despite the rejection from the 200 EMA, Injective is still holding above the weekly demand zone, which ranges from $14.1 to $19.1. This demand zone has previously provided strong support for price action, making it a key level for potential accumulation and DCAs (Dollar-Cost Averaging) for traders.
Currently, INJ is experiencing consolidation, which aligns with the broader market trend, as many altcoins are also in a sideways phase. Although we are not seeing a strong bullish move yet, the fact that the price remains above this crucial demand zone shows there is still support for Injective in the market.
Key levels to watch
- Upside resistance:
- $22.45 (200 EMA on the daily) - This is the first key level that Injective needs to break to show any signs of bullish reversal.
- $24.8 - If the price breaks above the 200 EMA, this is the next major resistance level that could see injective testing at higher levels in the medium term.
- Downside support:
- $19.1 - This is the first major support level on the downside and the upper bound of the weekly demand zone.
- $14.1 - $19.1 - The entire weekly demand zone remains a strong area for accumulation, especially if the price pulls back further. Traders can look at this range for potential long positions if the wider market supports a bullish reversal.
Market outlook
At this stage, Injective is consolidating without showing any clear bullish divergence or momentum on the daily timeframe. However, as long as it continues to hold above the weekly demand zone, there is potential for upside once the price breaks through the 200 EMA.For now, it's a waiting game to see how Injective performs, especially if the broader market starts picking up momentum.
Cryptonary's take
Injective is in a crucial consolidation phase, and while it's struggling to break the 200 EMA, the support from the weekly demand zone is holding well. For those looking to accumulate, the weekly demand zone remains a strong area for long-term positioning.If the market sentiment turns bullish and Injective manages to break through the 200 EMA, we could see a rally toward $24.8 in the short term. However, patience is key, and traders should keep an eye on the broader market for signs of momentum before making any major moves.
Recommended from Cryptonary
